Back to PRIM&R Home ConferenceHeader Register
  • Keynote Speakers

    November 6, 8:30-9:15 AM

    Amy D. MarcusAmy Dockser Marcus
    Staff Reporter, The Wall Street Journal

    Amy Dockser Marcus is a Pulitzer Prize winning writer for The Wall Street Journal (WSJ). She spent six years in an immersion "storytelling experiment" by embedding with families who had taken science into their own hands to save their children. In a 10-part, 17,000 word multi-media series titled, "Trials," Ms. Dockser Marcus captured the life and death journey of the families participating in new drug trials and treatments in a race against time to find a cure for their children's rare and fatal disease.

    Ms. Dockser Marcus began her journalism career as a reporter for the American Lawyer in New York in 1987. She joined the WSJ in July 1988 as a news assistant in the New York bureau and became a reporter, covering law, in October 1989. A year later, Ms. Dockser Marcus won first place in the New York State Bar Association's 1990 Media Awards Competition for a group of legal feature stories that covered such subjects as environmental liability for toxic-waste dumping, litigation over privacy rights, and new developments in libel law. In 1991, Ms. Dockser Marcus became a reporter in the WSJ's Tel Aviv bureau, where she covered Israel and the Middle East. She wrote two books that grew out of her reporting in the Middle East: The View From Nebo: How Archaeology Is Rewriting the Bible and Reshaping the Middle East (Little, Brown & Co., 2000) and Jerusalem 1913: The Origins of the Arab-Israeli Conflict (Viking, 2007).

    In 1999, Marcus joined the WSJ's Boston Bureau. In 2000, she left the paper to work for Money magazine, and returned to the WSJ two years later. In 2004, she received a week-long Harvard Medical School Media Fellowship focused on cancer research. In 2005, she won a Pulitzer Prize in the Beat Reporting category for her stories on the way state-of-the-art cancer treatments were creating new challenges for patients; the Eugene S. Pulliam Journalism Award from Ball State University; and the Deadline Club Award for specialized writing in science, technology, medical, or environmental reporting. In 2006, Ms. Dockser Marcus received a Robert Wood Johnson Foundation Investigator Award in health policy research, and the National Media Award from the National Down Syndrome Congress. Ms. Dockser Marcus is a graduate of Harvard University.

    November 7, 8:30-9:15 AM

    Rob CaliffRobert Califf, MD MACC
    Donald F. Fortin, MD, Professor of Cardiology; Professor of Medicine, Division of Cardiology, Duke University School of Medicine; Adjunct Professor of Medicine, Stanford University

    Robert Califf, MD MACC, is the Donald F. Fortin, MD, Professor of Cardiology, and a professor of medicine in the Division of Cardiology Duke University School of Medicine, He remains a practicing cardiologist, and is also an adjunct professor at Stanford University. Dr. Califf was the commissioner of food and drugs at the FDA (2016-2017) and, prior to that, was the deputy commissioner for medical products and tobacco at FDA from February 2015 until his appointment as commissioner in February 2016. Before joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute.

    A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature. Dr. Califf is a member of the National Academy of Medicine (formerly known as the Institute of Medicine (IOM)) in 2016, which is one of the highest honors in the fields of health and medicine. Dr. Califf has served on numerous IOM committees, and he has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology.

    Dr. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences, and the Council of the National Institute on Aging. He has led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative, a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke's Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center and co-principal investigator of the Patient Centered Outcomes Research Institute Network.

    November 8, 8:30-9:15 AM

    Robert WinnRobert A. Winn, MD
    Associate Vice Chancellor for Community-Based Practice; Director, University of Illinois Cancer Center, University of Illinois Hospital and Health Sciences System, Chicago; Professor of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois College of Medicine at Chicago

    Robert A. Winn, MD, is the associate vice chancellor for community-based practice; director of the University of Illinois Cancer Center (UI Cancer Center) at the University of Illinois Hospital and Health Sciences System (UI Health), Chicago, and a professor of medicine at the University of Illinois College of Medicine at Chicago, in the division of pulmonary, critical care, sleep and allergy.

    Dr. Winn oversees management of the UI Health Mile Square Health Center, a 13-site Federally Qualified Health Center network, which, by mission and design, exists to serve those who have limited access to care, though all are welcome. The intention behind Mile Square is to build a 21st Century model of community-based healthcare providers that reflects the mission of the academic health center; and develops meaningful research programs that, if adopted, can enhance the overall well-being of the community.

    As director of the UI Cancer Center and a specialist in pulmonary and critical care medicine, Dr. Winn is committed to leveraging community-based health initiatives to drive basic science research and banish healthcare disparities in some of the Chicago area's most vulnerable communities, and beyond. Dr. Winn is a principal investigator on various NIH and NCI-funded projects, such as ChicagoCHEC, the GUIDE Project, and the All of Us Precision Medicine Initiative. Dr. Winn also leads a basic science translational research lab focused on the mechanisms that drive cellular proliferation that lead to early cell death and lung cancer.

    In addition to his administrative/research responsibilities, Dr. Winn continues to care for patients in his lung nodule clinic. Prior to joining the UI Health, Dr. Winn was an associate professor in the department of medicine in the division of pulmonary/critical care medicine at the University of Colorado Health Sciences Center. Dr. Winn has also served as associate dean of admissions at the School of Medicine; vice chair of medicine in the department of medicine; and senior medical director for the University of Colorado Multidisciplinary Pulmonary Clinic. As a specialist in pulmonary and critical care, Dr. Winn practiced at the University Hospital and the Veteran Affairs Medical Center in Denver, CO.

    Dr. Winn received his medical degree from the University of Michigan Medical School in Ann Arbor, and completed his medical residency in internal medicine at Rush Presbyterian St. Luke's Medical Center, Chicago, where he served as a chief resident. Dr. Winn's fellowship in pulmonary/critical care medicine was completed at the University of Colorado School of Medicine, National Jewish Health. In addition, Dr. Winn has led, served on, and contributed to a multitude of diverse committees to help develop the next generation of physician-scientists. Dr. Winn is the recipient of numerous awards for excellence in teaching, scholarship, leadership, diversity, and service. Significant memberships include: American Association of Cancer Research, Minorities in Cancer Research Council (2016-present); NIH Precision Medicine Initiative (All of Us), Scientific Vision Committee (2016-present); Project Echo Board of Directors (2016-present); and the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine (joined in 2017).